---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-015388"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2024-04-19T23:59:59+00:00"
generated_at: "2026-06-03T15:40:42.783370+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# INVO Bioscience receives Nasdaq delisting notice for equity non-compliance; lease assignment nets $475K

## Summary
- Nasdaq staff determined to delist INVO due to stockholders' equity of $892,825, below the $2.5M minimum.
- Company intends to appeal by April 24, 2024; stock continues trading on Nasdaq pending hearing.
- INVO Centers assigned Tampa lease to Brown Fertility for $475,000; used $356,547 to pay landlord for buildout and rent.
- Remaining lease proceeds allocated to working capital; company shifting focus to acquiring profitable fertility clinics.

## SEC filing metadata
- accession: 0001493152-24-015388
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2024-04-19T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.02, 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315224015388/0001493152-24-015388-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315224015388/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-015388
- JSON: https://secwatch.observer/filing/0001493152-24-015388.json
- Plain text: https://secwatch.observer/filing/0001493152-24-015388.txt

## Key facts
- Listing & Compliance Notices
  INVO Fertility, Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: April 17, 2024, the Company, having reported, on April 16, 2024, stockholders’ equity of $892,825 in the Form 10-K for the period ended December 31, 2023, received notice (the “Notice”) from the staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it no longer complies with Nasdaq Listing Rule 5550(b)(1) that requires companies listed on The Nasdaq Capital Market to maintain stockholders’ equity of at least $2,500,000 (the “Equity Rule”). In a decision dated November 22, 2023, a Nasdaq Hearings Panel (the “Panel”) previously had confirmed that the Company reg
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315224015388/0001493152-24-015388-index.htm
- Material Agreements
  INVO Fertility, Inc. terminated a lease with Brown Fertility Associates PA (effective 2024-04-19).
  - Action: termination
  - Agreement: lease
  - Counterparty: Brown Fertility Associates PA
  - Effective: 2024-04-19
  source text: On April 19, 2024, INVO Centers LLC ("INVO Centers"), a wholly owned subsidiary of INVO Bioscience, Inc. (the "Company"), completed the assignment to Brown Fertility Associates PA ("Brown Fertility") of its lease with 4602 North Armenia Ave, LLC (the "Landlord"), for the property located at 4602 North Armenia Avenue, Suite 200, Tampa, LLC (the "Premises").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315224015388/0001493152-24-015388-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.